Sean Godbout

All filings by Sean Godbout on record concern Biogen Inc. In total, 6 filings cover trades dated from 2 October 2025 to 2 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 5 October 2026: an option exercise, in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.